Endothelial Activation and Stress Index Score as a Prognostic Factor of Cytokine Release Syndrome in CAR-T Patients – A Retrospective Analysis of Multiple Myeloma and Large B-Cell Lymphoma Cohorts
By:
References
- Almici C, Skert C, Verardi R et al (2014) Changes in circulating endothelial cells count could become a valuable tool in the diagnostic definition of acute graft-versus-host disease. Transplantation 98:706–712. https://doi.org/10.1097/tp.0000000000000385
- Asherie N, Kfir-Erenfeld S, Avni B et al (2023) Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial. Haematologica 108:1827–1839. https://doi.org/10.3324/haematol.2022.281628
-
Biedermann BC, Sahner S, Gregor M et al (2002) Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet 359:2078–2083.
https://doi.org/10.1016/s0140-6736(02)08907-9
BiedermannBC SahnerS GregorM 2002 Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease Lancet 359 2078 2083 https://doi.org/10.1016/s0140-6736(02)08907-9
- Cordes S, Mokhtari Z, Bartosova M et al (2021) Endothelial damage and dysfunction in acute graft-versus-host disease. Haematologica 106:2147–2160. https://doi.org/10.3324/haematol.2020.253716
- Eelen G, de Zeeuw P, Treps L et al (2018) Endothelial cell metabolism. Physiol Rev 98:3–58. https://doi.org/10.1152/physrev.00001.2017
- Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27–31. https://doi.org/10.1038/nm0195-27
- Greenbaum U, Strati P, Saliba RM et al (2020) The EASIX (Endothelial Activation and Stress Index) score predicts for CAR T related toxicity in patients receiving axicabtagene ciloleucel (axi-cel) for non-Hodgkin lymphoma (NHL). Blood 136(Supplement 1):-17–18. https://doi.org/10.1182/blood-2020-141388
- Greenbaum U, Strati P, Saliba RM et al (2021) CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity. Blood Adv 5:2799–2806. https://doi.org/10.1182/bloodadvances.2021004575
- Gust J, Ponce R, Liles WC et al (2020) Cytokines in CAR T cell-associated neurotoxicity. Front Immunol 11:577027. https://doi.org/10.3389/fimmu.2020.577027
- Hay KA, Hanafi LA, Li D et al (2017) Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy. Blood 130:2295–2306. https://doi.org/10.1182/blood-2017-06-793141
- Korell F, Penack O, Mattie M et al (2022) EASIX and severe endothelial complications after CD19-directed CAR-T cell therapy-a cohort study. Front Immunol 13:877477. https://doi.org/10.3389/fimmu.2022.877477
- Lee DW, Santomasso BD, Locke FL et al (2019) ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant 25:625–638. https://doi.org/10.1016/j.bbmt.2018.12.758
- Lee J, Upreti HV, Sannareddy A et al (2024) Pre-lymphodepletion Endothelial Activation and Stress Index as a predictor of clinical outcomes in B-cell maturation antigen CAR T therapy for multiple myeloma. Transplantat Cell Ther 30(Supplement):S221–S222. https://doi.org/10.1016/j.jtct.2023.12.288
-
Luft T, Benner A, Jodele S et al (2017) EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis. Lancet Haematol 4:e414–e423.
https://doi.org/10.1016/s2352-3026(17)30108-4
LuftT BennerA JodeleS 2017 EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis Lancet Haematol 4 e414 e423 https://doi.org/10.1016/s2352-3026(17)30108-4
- Luft T, Benner A, Terzer T et al (2020) EASIX and mortality after allogeneic stem cell transplantation. Bone Marrow Transplant 55:553–561. https://doi.org/10.1038/s41409-019-0703-1
- Mariotti J, Magri F, Giordano L et al (2023) EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide. Bone Marrow Transplant 58:247–256. https://doi.org/10.1038/s41409-022-01874-5
- Menzel L, Höpken UE, Rehm A (2020) Angiogenesis in lymph nodes is a critical regulator of immune response and lymphoma growth (Review). Front Immunol 11:591741. https://doi.org/10.3389/fimmu.2020.591741
- Merz A, Germing U, Kobbe G et al (2019) EASIX for prediction of survival in lower-risk myelodysplastic syndromes. Blood Cancer J 9:85. https://doi.org/10.1038/s41408-019-0247-z
- Molema G (2010) Heterogeneity in endothelial responsiveness to cytokines, molecular causes, and pharmacological consequences. Semin Thromb Hemost 36:246–264. https://doi.org/10.1055/s-0030-1253448
- Page AV, Liles WC (2013) Biomarkers of endothelial activation/dys-function in infectious diseases. Virulence 4:507–516. https://doi.org/10.4161/viru.24530
- Palomo M, Diaz-Ricart M, Carbo C et al (2010) Endothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantation. Biol Blood Marrow Transplant 16:985–993. https://doi.org/10.1016/j.bbmt.2010.02.008
- Park S, Go SI, Lee GW (2022) The Endothelial Activation and Stress Index (EASIX) score is an independent prognostic factor in patients with diffuse large B-cell lymphoma. BMC Cancer 22:816. https://doi.org/10.1186/s12885-022-09915-4
- Penack O, Henke E, Suh D et al (2010) Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth. J Natl Cancer Inst 102:894–908. https://doi.org/10.1093/jnci/djq172
- Pennisi M, Sanchez-Escamilla M, Flynn JR et al (2021) Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells. Blood Adv 5: 3397–3406. https://doi.org/10.1182/bloodadvances.2020003885
- Rajendran P, Rengarajan T, Thangavel J et al (2013) The vascular endothelium and human diseases. Int J Biol Sci 9:1057–1069. https://doi.org/10.7150/ijbs.7502
- Riesner K, Shi Y, Jacobi A et al (2017) Initiation of acute graft-versus-host disease by angiogenesis. Blood 129:2021–2032. https://doi.org/10.1182/blood-2016-08-736314
- Sidana S, Hosoya H, Jensen A et al (2023) Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma. Blood Cancer J 13:158. https://doi.org/10.1038/s41408-023-00929-0
- Song GY, Jung SH, Kim K et al (2020) Endothelial Activation and Stress Index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma. BMC Cancer 20:803. https://doi.org/10.1186/s12885-020-07317-y
- Thanhakun R, Wudhikarn K, Bunworasate U et al (2023) Endothelial Activation and Stress Index as a prognostic factor of diffuse large B-cell lymphoma: the report from the nationwide multi-center Thai Lymphoma Study Group. Ann Hematol 102:3533–3541. https://doi.org/10.1007/s00277-023-05437-6
- Tomasik J, Drozd-Sokołowska J, Kacprzyk P et al (2023) Tisagenlecleucel CAR-T for relapsed/refractory diffuse large B-cell lymphoma, one therapy; two different clinical presentations. An urgent need to design adverse event predictors. Acta Haematologica Polonica 54:100–103. https://doi.org/10.5603/AHP.a2023.0018
- Trepels T, Zeiher AM, Fichtlscherer S (2006) The endothelium and inflammation. Endothelium 13:423–429. https://doi.org/10.1080/10623320601061862
- von Elm E, Altman DG, Egger M et al (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61:344–349. https://doi.org/10.1016/j.jclinepi.2007.11.008
- Zhang X, Zhu L, Zhang H et al (2022) CAR-T cell therapy in hemato-logical malignancies: current opportunities and challenges. Front Immunol 13:927153. https://doi.org/10.3389/fimmu.2022.927153
DOI: https://doi.org/10.2478/aite-2024-0018 | Journal eISSN: 1661-4917
Language: English
Submitted on: May 18, 2024
Accepted on: Aug 2, 2024
Published on: Sep 14, 2024
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Keywords:
Related subjects:
© 2024 Jaromir Tomasik, Batia Avni, Sigal Grisariu, Shlomo Elias, Eran Zimran, Polina Stepensky, Grzegorz W. Basak, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.